Interference Peak [Bioanalytics]

posted by Dr. Harish L. Rao – India, 2007-09-20 11:42 (6057 d 00:41 ago) – Posting: # 1096
Views: 4,786

(edited by Dr. Harish L. Rao on 2007-09-20 11:56)

Dear Group Members,

During subject plasma sample analysis by LC/MS/MS, an extra peak (possibly due to metabolite) is observed which is not completely separated from the drug peak. But Method Validation was performed without the metabolite (as per OGD communication) & there was no interference peak during method validation. In such a situation, how should the analyst proceed with subject sample analysis?

Thanks & regards,
Dr. Harish L. Rao

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,657 registered users;
110 visitors (0 registered, 110 guests [including 10 identified bots]).
Forum time: 12:24 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5